Chang Kyung Kang, MD, PhD

Seoul National University College of Medicine
Seoul, Seoul-t'ukpyolsi, Republic of Korea

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 90 - Impact of anti-CD20 therapy on COVID-19 in immunocompromised patients: A nationwide cohort study in Korea

  Thursday, October 17, 2024
  11:06 AM – 11:18 AM US PT